1. Alirocumab reduces total coronary plaque burden in patients with familial hypercholesterolaemia and no previous clinical atherosclerotic disease. (3rd October 2022) Authors: Perez De Isla, L; Diaz Diaz, J L; Romero, M J; Muniz Grijalvo, O; Argueso, R; Sanchez Munoz Torrero, J F; Mediavilla, J D; Ponte, P; Fuentes, F; Saltijeral Cerezo, A; Alvarez Banos, P; Rubio, P; Cepeda, J M; Padro, T; Mata, P Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗